trial
as of 2026-07-01Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
NCTId NCT00716755
at a glance
— · Completed
Enrollment 45 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2015-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
45 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2009-10
Primary completion
2015-08
Eligibility
ALL · 50 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
2
David C. Mamo, MD, MScPrincipal Investigator
Ariel Graff-Guerrero, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
45
Phase
NA
Primary Completion Date
2015-08
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
indication
indication
indication
investigator